share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Floyd Eric

SEC announcement ·  Jan 31 16:30
Summary by Moomoo AI
In a recent transaction, Eric Floyd, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Eric Floyd to the issuer was also not specified. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
In a recent transaction, Eric Floyd, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Eric Floyd to the issuer was also not specified. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more